Anna Kramvis to Antiviral Agents
This is a "connection" page, showing publications Anna Kramvis has written about Antiviral Agents.
Connection Strength
1,473
-
Retrospective characterization of the S open reading frame of HBV isolated from children with membranous nephropathy treated with interferon-alpha2b. Antivir Ther. 2010; 15(1):61-9.
Score: 0,323
-
Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat. 2005 Sep; 12(5):456-64.
Score: 0,239
-
Molecular characterization and genotyping of hepatitis C virus from Sudanese end-stage renal disease patients on haemodialysis. BMC Infect Dis. 2022 Nov 14; 22(1):848.
Score: 0,197
-
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. Nat Rev Gastroenterol Hepatol. 2022 11; 19(11):727-745.
Score: 0,193
-
Molecular characterization of hepatitis B virus (HBV) isolated from a pediatric case of acute lymphoid leukemia, with a delayed response to antiviral treatment: a case report. BMC Pediatr. 2022 03 31; 22(1):168.
Score: 0,189
-
The hepatitis B epidemic and the urgent need for cure preparedness. Nat Rev Gastroenterol Hepatol. 2018 09; 15(9):517-518.
Score: 0,147
-
Navigating paediatric virology through the COVID-19 era (Review). Int J Mol Med. 2023 Sep; 52(3).
Score: 0,052
-
Treatment of hepatitis B virus-associated nephropathy in black children. Pediatr Nephrol. 2002 Jun; 17(6):393-9.
Score: 0,048
-
In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral Vectors. Viruses. 2021 11 09; 13(11).
Score: 0,046
-
A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol. 2019 07; 4(7):545-558.
Score: 0,038